RMD · Resmed Inc
$224.46
-2.28 (-1.01%)
At close · Aug 14
Market Cap
$32.38B
Shares
144.25M
Resmed Inc Earnings Call Transcripts
Every quarterly earnings call for Resmed Inc (RMD) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲5.1%
$950.29M
$210.48M
'23 Q1
22-10-27
▲15.5%
$1.03B
$224.91M
'23 Q2
23-01-26
▲29.2%
$1.12B
$232.50M
'23 Q3
23-04-27
▲22.7%
$1.12B
$229.66M
'23 Q4
23-08-03
▲16%
$1.10B
$219.42M
'24 Q1
23-10-26
▲12.5%
$1.16B
$208.80M
'24 Q2
24-01-24
▲7.2%
$1.20B
$300.49M
'24 Q3
24-04-25
▲9%
$1.22B
$292.24M
'24 Q4
24-08-01
▲11.1%
$1.22B
$311.36M
'25 Q1
24-10-24
▲10.3%
$1.28B
$344.62M
'25 Q2
25-01-30
▲7.9%
$1.29B
$365.04M
'25 Q3
25-04-23
▲10.2%
$1.35B
$379.70M
'25 Q4
25-07-31
▲9.1%
$1.34B
$348.54M
'26 Q1
25-10-30
▲11%
$1.42B
$392.59M
'26 Q2
26-01-29
▲10.8%
$1.43B
$398.73M
'26 Q3
26-04-30
LATEST
▲8.6%
$1.46B
$383.43M
'26 Q4
26-07-07
Earnings call
FY26 · Q4
2026-07-07
Resmed Inc Q4 FY2026 Earnings Call
Confident tone
Device Platform Innovation
GLP-1 Medications as Tailwind
Revenue and Earnings Growth
Revenue
$1.46B*
▲ 8.6% YoY Gross margin
58.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Capital Markets Day
Investor event
2026-07-07
MatrixCare Business Divestiture Presentation
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
William Blair Growth Stock Conference Presentation
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-02
William Blair Growth Stock Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-04-30
Resmed Inc Q3 FY2026 Earnings Call
Confident tone
Sleep apnea clinical evidence and CME
GLP-1 / Eli Lilly combination therapy opportunity
Leadership transition (CFO)
Revenue
$1.43B
▲ 10.8% YoY Diluted EPS
$2.74
▲ 10.5% YoY Gross margin
62.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-01-29
Resmed Inc Q2 FY2026 Earnings Call
Confident tone
GLP-1 drugs as a tailwind
Mask portfolio expansion and reacceleration
Residential Care Software (RCS) portfolio management
Revenue
$1.42B
▲ 11% YoY Diluted EPS
$2.68
▲ 14.5% YoY Gross margin
61.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-01-12
JPM 2026 Healthcare Conference Presentation
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2025-10-30
Resmed Inc Q1 FY2026 Earnings Call
Revenue
$1.34B
▲ 9.1% YoY Diluted EPS
$2.37
▲ 12.3% YoY Gross margin
61.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-07-31
Resmed Inc Q4 FY2025 Earnings Call
Confident tone
GLP-1 and patient demand generation
Acquisitions and inorganic growth
Revenue and earnings growth
Revenue
$1.35B*
▲ 10.2% YoY Gross margin
60.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-04-23
Resmed Inc Q3 FY2025 Earnings Call
Revenue
$1.29B
▲ 7.9% YoY Diluted EPS
$2.48
▲ 21.6% YoY Gross margin
59.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-01-30
Resmed Inc Q2 FY2025 Earnings Call
Confident tone
Consumer tech / medtech convergence (Apple, Samsung, CES)
GLP-1 drugs and sleep apnea awareness
Gross margin expansion
Revenue
$1.28B
▲ 10.3% YoY Diluted EPS
$2.34
▲ 64.8% YoY Gross margin
58.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-10-24
Resmed Inc Q1 FY2025 Earnings Call
Revenue
$1.22B
▲ 11.1% YoY Diluted EPS
$2.11
▲ 41.6% YoY Gross margin
58.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2024-08-01
Resmed Inc Q4 FY2024 Earnings Call
Confident tone
Geographic expansion and global reach
GLP-1 / pharma megatrend
Masks and accessories business
Revenue
$1.22B*
▲ 9% YoY Gross margin
58.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-04-25
Resmed Inc Q3 FY2024 Earnings Call
Revenue
$1.20B
▲ 7.2% YoY Diluted EPS
$2.04
▲ 29.1% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-01-24
Resmed Inc Q2 FY2024 Earnings Call
Revenue
$1.16B
▲ 12.5% YoY Diluted EPS
$1.42
▼ 7.2% YoY Gross margin
55.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-10-26
Resmed Inc Q1 FY2024 Earnings Call
Revenue
$1.10B
▲ 16% YoY Diluted EPS
$1.49
▲ 4.2% YoY Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-08-03
Resmed Inc Q4 FY2023 Earnings Call
Revenue
$1.12B*
▲ 22.7% YoY Gross margin
55.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-04-27
Resmed Inc Q3 FY2023 Earnings Call
Revenue
$1.12B
▲ 29.2% YoY Diluted EPS
$1.58
▲ 29.5% YoY Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-01-26
Resmed Inc Q2 FY2023 Earnings Call
Revenue
$1.03B
▲ 15.5% YoY Diluted EPS
$1.53
▲ 11.7% YoY Gross margin
56.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2022-10-27
Resmed Inc Q1 FY2023 Earnings Call
Revenue
$950.29M
▲ 5.1% YoY Diluted EPS
$1.43
▲ 2.9% YoY Gross margin
56.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-08-11
Resmed Inc Q4 FY2022 Earnings Call
Revenue
$914.74M*
▲ 4.4% YoY Gross margin
57.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-04-28
Resmed Inc Q3 FY2022 Earnings Call
Revenue
$864.50M
▲ 12.5% YoY Diluted EPS
$1.22
Gross margin
56.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-01-27
Resmed Inc Q2 FY2022 Earnings Call
Revenue
$894.87M
▲ 11.9% YoY Diluted EPS
$1.37
▲ 11.4% YoY Gross margin
56.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-10-28
Resmed Inc Q1 FY2022 Earnings Call
Revenue
$904.01M
▲ 20.2% YoY Diluted EPS
$1.39
▲ 13.9% YoY Gross margin
56.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-08-05
Resmed Inc Q4 FY2021 Earnings Call
Revenue
$876.10M*
▲ 13.7% YoY Gross margin
56.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-04-29
Resmed Inc Q3 FY2021 Earnings Call
Revenue
$768.77M
▼ 0.1% YoY Diluted EPS
$-0.54
▼ 148.2% YoY Gross margin
58.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-01-28
Resmed Inc Q2 FY2021 Earnings Call
Revenue
$800.01M
▲ 8.7% YoY Diluted EPS
$1.23
▲ 11.8% YoY Gross margin
57.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-10-29
Resmed Inc Q1 FY2021 Earnings Call
Revenue
$751.94M
▲ 10.4% YoY Diluted EPS
$1.22
▲ 47% YoY Gross margin
58.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-08-05
Resmed Inc Q4 FY2020 Earnings Call
Revenue
$770.35M*
▲ 9.3% YoY Gross margin
58.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-04-30
Resmed Inc Q3 FY2020 Earnings Call
Revenue
$769.46M
▲ 16.2% YoY Diluted EPS
$1.12
▲ 53.4% YoY Gross margin
58.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-01-30
Resmed Inc Q2 FY2020 Earnings Call
Revenue
$736.16M
▲ 13.1% YoY Diluted EPS
$1.10
▲ 27.9% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2019-09-30
Resmed Inc Q1 FY2020 Earnings Call
Revenue
$681.06M
▲ 15.8% YoY Diluted EPS
$0.83
▲ 13.7% YoY Gross margin
57.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–32 of 32 earnings calls
Key facts
CIK
943819
CUSIP
761152107
13F (30d)
803 filings
771 filers
Visit website
Investor relations